In general terms, it seems that, in glioma cells, stemness and mesenchymal phenotype are closely linked: knockdown of genes directly involved in EMT, such ZEB1, also causes inhibition of stem cell regulators like Sox2 and Olig2 [150]. Here, OLIG2 is linked to central nervous system cancer.